Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Authors:
- Karen De VreeseKVKaren De Vreese
- Tom Van de CasteeleTCTom Van de Casteele
- Hugo VandersticheleHVHugo Vanderstichele
- Bart Van EverbroeckBEBart Van Everbroeck
- Patrick CrasPCPatrick Cras
- Jean-Jacques MartinJMJean-Jacques Martin
- Eugeen VanmechelenEVEugeen Vanmechelen
- Peter Paul De DeynPDPeter Paul De Deyn
- 1 August 2008
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (8) , 1143-1159
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's diseaseAnnals of Neurology, 2005
- CSF biomarkers for mild cognitive impairment and early Alzheimer's diseaseClinical Neurology and Neurosurgery, 2005
- Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer DiseaseArchives of General Psychiatry, 2004
- Cerebrospinal Fluid Tau and β-AmyloidArchives of Neurology, 2003
- CSF markers for pathogenic processes in Alzheimer’s disease: diagnostic implications and use in clinical neurochemistryBrain Research Bulletin, 2003
- CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxiaBrain, 2001
- Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical PracticeArchives of Neurology, 2001
- High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E GenotypeArchives of Neurology, 1998
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- “Mini-mental state”Journal of Psychiatric Research, 1975